{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:34:52Z","timestamp":1790354092392,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Neurological and Psychiatric Disorders of NCNP","award":["5-3"],"award-info":[{"award-number":["5-3"]}]},{"name":"JSPS KAKENHI","award":["JP21K17478"],"award-info":[{"award-number":["JP21K17478"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05319-7","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:40:38Z","timestamp":1748943638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional improvement by tendon transfer for residual wrist dysfunction after botulinum therapy for severe upper limb spasticity: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Takatoshi","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naho","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Abo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"5319_CR1","unstructured":"Lance JW. Symposium synopsis. Spasticity: disordered motor control. Year Book Medical Publishers: Chicago."},{"key":"5319_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","volume":"35","author":"DK Sommerfeld","year":"2004","unstructured":"Sommerfeld DK, Eek EU, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35:134\u20139.","journal-title":"Stroke"},{"key":"5319_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1191\/0269215502cr512oa","volume":"16","author":"CL Watkins","year":"2002","unstructured":"Watkins CL, Leathley MJ, Gregson JM, et al. Prevalence of spasticity post stroke. Clin Rehabil. 2002;16:515\u201322.","journal-title":"Clin Rehabil"},{"key":"5319_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0028-3843(14)60300-5","volume":"44","author":"M Schinwelsk","year":"2010","unstructured":"Schinwelsk M, S\u0142awek J. Prevalence of spasticity following stroke and its impact on quality of life with emphasis on disability in activities of daily living. Systematic Rev Neurol Neurochir. 2010;44:404\u201311.","journal-title":"Systematic Rev Neurol Neurochir"},{"key":"5319_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","volume":"6","author":"MF Brin","year":"1997","unstructured":"Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity and immunology. Muscle Nerve Suppl. 1997;6:146\u201368.","journal-title":"Muscle Nerve Suppl"},{"key":"5319_CR6","first-page":"32","volume":"42","author":"RN Boyd","year":"2000","unstructured":"Boyd RN, Pliatsios V, Starr R, et al. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin a in children with cerebral palsy. Dev Med Child Neurol. 2000;42:32\u201341.","journal-title":"Dev Med Child Neurol"},{"key":"5319_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MRR.0b013e328332f5e0","volume":"33","author":"AM Bakheit","year":"2010","unstructured":"Bakheit AM, Zakine B, Maisonobe P, et al. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type a: an international survey. Int J Rehabil Res. 2010;33:199\u2013204.","journal-title":"Int J Rehabil Res"},{"key":"5319_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/toxins11120707","volume":"11","author":"T Hara","year":"2019","unstructured":"Hara T, Momosaki R, Niimi M, et al. Botulinum toxin therapy combined with rehabilitation for stroke: a systematic review of effect on motor function. Toxins (Basel). 2019;11:707.","journal-title":"Toxins (Basel)"},{"key":"5319_CR9","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1080\/09638288.2021.1977394","volume":"44","author":"T Hara","year":"2022","unstructured":"Hara T, Niimi M, Yamada N, et al. Prognosis prediction of the effect of botulinum toxin therapy and intensive rehabilitation on the upper arm function in post-stroke patients using hierarchical cluster analysis. Disabil Rehabil. 2022;44:6815\u201323.","journal-title":"Disabil Rehabil"},{"key":"5319_CR10","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.apmr.2019.01.016","volume":"100","author":"A Andringa","year":"2019","unstructured":"Andringa A, van de Port I, van Wegen E, et al. Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2019;100:1703\u201325.","journal-title":"Arch Phys Med Rehabil"},{"key":"5319_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/toxins10090349","volume":"10","author":"T Hara","year":"2018","unstructured":"Hara T, Abo M, Hara H, et al. The effect of repeated botulinum toxin a therapy combined with intensive rehabilitation on lower limb spasticity in post-stroke patients. Toxins (Basel). 2018;10:349.","journal-title":"Toxins (Basel)"},{"key":"5319_CR12","first-page":"83","volume":"128","author":"K Tagushi","year":"2013","unstructured":"Tagushi K, Yoshizawa I, Matsuura S, et al. Combination treatment with surgery, botulinum toxin A injection, and occupational therapy for spastic upper limb hemiparesis with severe contracture. Jikeikai med. 2013;128:83\u20138.","journal-title":"Jikeikai med"},{"key":"5319_CR13","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/jnnp.2003.035139","volume":"75","author":"AM Bakheit","year":"2004","unstructured":"Bakheit AM, Fedorova NV, Skoromets AA, et al. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J Neurol Neurosurg Psychiatry. 2004;75:1558\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5319_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1468-1331.2006.01652.x","volume":"13","author":"M Naumann","year":"2006","unstructured":"Naumann M, Albanese A, Heinen F, et al. Safety and efficacy of botulinum toxin type A following long-term use. Eur J Neurol. 2006;13:35\u201340.","journal-title":"Eur J Neurol"},{"key":"5319_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/jhsu.1999.0944","volume":"24","author":"GM Rayan","year":"1999","unstructured":"Rayan GM, Young BT. Arthrodesis of the spastic wrist. J Hand Surg Am. 1999;24:944\u201352.","journal-title":"J Hand Surg Am"},{"key":"5319_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1468-1331.2010.03129.x","volume":"17","author":"G Sheean","year":"2010","unstructured":"Sheean G, Lannin NA, Turner-Stokes L, et al. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17:74\u201393.","journal-title":"Eur J Neurol"},{"key":"5319_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2014.09.016","volume":"347","author":"A Santamato","year":"2014","unstructured":"Santamato A, Micello MF, Panza F, et al. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J Neurol Sci. 2014;347:39\u201343.","journal-title":"J Neurol Sci"},{"key":"5319_CR18","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1161\/01.STR.32.8.1875","volume":"32","author":"SM Michaelsen","year":"2001","unstructured":"Michaelsen SM, Luta A, Roby-Brami A, et al. Effect of trunk restraint on the recovery of reaching movements in hemiparetic patients. Stroke. 2001;32:1875\u201383.","journal-title":"Stroke"},{"key":"5319_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apmr.2005.08.113","volume":"87","author":"MY Pang","year":"2006","unstructured":"Pang MY, Harris JE, Eng JJ. A community-based upper-extremity group exercise program improves motor function and performance of functional activities in chronic stroke: a randomized controlled trial. Arch Phys Med Rehabil. 2006;87:1\u20139.","journal-title":"Arch Phys Med Rehabil"},{"key":"5319_CR20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Gracies JM, Graham HK, et al. Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691\u20138.","journal-title":"Neurology"},{"key":"5319_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2340\/16501977-0303","volume":"41","author":"J Wissel","year":"2009","unstructured":"Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009;41:13\u201325.","journal-title":"J Rehabil Med"},{"key":"5319_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/00207454.2016.1196204","volume":"127","author":"T Hara","year":"2017","unstructured":"Hara T, Abo M, Hara H, et al. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients. Int J Neurosci. 2017;127:469\u201378.","journal-title":"Int J Neurosci"},{"key":"5319_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2522\/ptj.20110009","volume":"92","author":"SJ Page","year":"2012","unstructured":"Page SJ, Fulk GD, Boyne P. Clinically important differences for the upper-extremity Fugl\u2013Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Phys Ther. 2012;92:791\u20138.","journal-title":"Phys Ther"},{"key":"5319_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/BPO.0b013e3181831eac","volume":"28","author":"AE Van Heest","year":"2008","unstructured":"Van Heest AE, Ramachandran V, Stout J, et al. Quantitative and qualitative functional evaluation of upper extremity tendon transfers in spastic hemiplegia caused by cerebral palsy. J Pediatr Orthop. 2008;28:679\u201383.","journal-title":"J Pediatr Orthop"},{"key":"5319_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1469-8749.2007.00385.x","volume":"49","author":"JC van Munster","year":"2007","unstructured":"van Munster JC, Maathuis KG, Haga N, et al. Does surgical management of the hand in children with spastic unilateral cerebral palsy affect functional outcome? Dev Med Child Neurol. 2007;49:385\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"5319_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40272-019-00344-8","volume":"21","author":"I Multani","year":"2019","unstructured":"Multani I, Manji J, Hastings-Ison T, et al. Botulinum toxin in the management of children with cerebral palsy. Paediatr Drugs. 2019;21:261\u201381.","journal-title":"Paediatr Drugs"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05319-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:40:41Z","timestamp":1748943641000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05319-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5319"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05319-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The treatment of this case was carried out in accordance with the Declaration of Helsinki and with the approval of the Ethics Committee of the National Center of Neurology and Psychiatry (A2020-073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}